These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17493550)

  • 1. Peroxisome proliferator-activated receptor gamma polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes.
    Pollex RL; Mamakeesick M; Zinman B; Harris SB; Hegele RA; Hanley AJ
    J Diabetes Complications; 2007; 21(3):166-71. PubMed ID: 17493550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor-gamma2 P12A and type 2 diabetes in Canadian Oji-Cree.
    Hegele RA; Cao H; Harris SB; Zinman B; Hanley AJ; Anderson CM
    J Clin Endocrinol Metab; 2000 May; 85(5):2014-9. PubMed ID: 10843190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator activated receptor γ2 gene Pro12Ala gene polymorphism in type 2 diabetes and its relationship with diabetic nephropathy.
    Azab MM; Abdel-Azeez HA; Zanaty MF; El Alawi SM
    Clin Lab; 2014; 60(5):743-9. PubMed ID: 24839816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study.
    Herrmann SM; Ringel J; Wang JG; Staessen JA; Brand E;
    Diabetes; 2002 Aug; 51(8):2653-7. PubMed ID: 12145184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Pro12Ala polymorphism and albuminuria in type 2 diabetic nephropathy.
    Chen YN; Wang PW; Tung SC; Kuo MC; Weng SW; Chou CK; Chang CM; Tsa CJ; Taso CF; Shen FC; Chen JF
    J Diabetes Investig; 2020 Jul; 11(4):923-929. PubMed ID: 31912623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of peroxisome proliferator-activated receptor γ Pro12Ala gene polymorphism with type 2 diabetic nephropathy risk in Caucasian population.
    Zhou TB; Guo XF; Yin SS
    J Recept Signal Transduct Res; 2014 Jun; 34(3):180-4. PubMed ID: 24329532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 gene might be a risk factor for diabetic retinopathy in Slovene population (Caucasians) with type 2 diabetes and the Pro12Ala polymorphism of the PPARgamma gene is not.
    Petrovic MG; Kunej T; Peterlin B; Dovc P; Petrovic D
    Diabetes Metab Res Rev; 2005; 21(5):470-4. PubMed ID: 15782399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients.
    Liu L; Zheng T; Wang F; Wang N; Song Y; Li M; Li L; Jiang J; Zhao W
    Diabetes Care; 2010 Jan; 33(1):144-9. PubMed ID: 19837787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala Is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies.
    Zhang H; Zhu S; Chen J; Tang Y; Hu H; Mohan V; Venkatesan R; Wang J; Chen H
    Diabetes Care; 2012 Jun; 35(6):1388-93. PubMed ID: 22619290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of the peroxisome proliferator-activated receptor-gamma 2 exon 2 and exon 6 gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy.
    Erdogan M; Karadeniz M; Eroglu Z; Tezcanli B; Selvi N; Yilmaz C
    Diabetes Res Clin Pract; 2007 Dec; 78(3):355-9. PubMed ID: 17681394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population.
    Meshkani R; Taghikhani M; Larijani B; Bahrami Y; Khatami S; Khoshbin E; Ghaemi A; Sadeghi S; Mirkhani F; Molapour A; Adeli K
    Clin Chem Lab Med; 2007; 45(4):477-82. PubMed ID: 17439324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes.
    Caramori ML; Canani LH; Costa LA; Gross JL
    Diabetes; 2003 Dec; 52(12):3010-3. PubMed ID: 14633865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PPARγ2 Pro12Ala variant is protective against progression of nephropathy in people with type 2 diabetes.
    Lapice E; Monticelli A; Cocozza S; Pinelli M; Cocozza S; Bruzzese D; Riccardi G; Vaccaro O
    J Transl Med; 2015 Mar; 13():85. PubMed ID: 25889595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between PPARγ Pro12Ala gene polymorphism and type 2 diabetic nephropathy risk in Asian population: results from a meta-analysis.
    Liu G; Zhou TB; Jiang Z; Zheng D; Yuan F; Li Y; Hu H; Chen Z
    J Recept Signal Transduct Res; 2014 Apr; 34(2):131-6. PubMed ID: 24303936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone.
    Florez JC; Jablonski KA; Sun MW; Bayley N; Kahn SE; Shamoon H; Hamman RF; Knowler WC; Nathan DM; Altshuler D;
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1502-9. PubMed ID: 17213274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in PPARG encoding peroxisome proliferator-activated receptor gamma associated with carotid atherosclerosis.
    Al-Shali KZ; House AA; Hanley AJ; Khan HM; Harris SB; Zinman B; Mamakeesick M; Fenster A; Spence JD; Hegele RA
    Stroke; 2004 Sep; 35(9):2036-40. PubMed ID: 15284449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the PPARG P12A and C161T gene variants on serum lipids in coronary heart disease patients with and without Type 2 diabetes.
    Yilmaz-Aydogan H; Kurnaz O; Kurt O; Akadam-Teker B; Kucukhuseyin O; Tekeli A; Isbir T
    Mol Cell Biochem; 2011 Dec; 358(1-2):355-63. PubMed ID: 21833536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the PPARGC1A gene polymorphism with diabetic nephropathy in an Asian Indian population (CURES-41).
    Gayathri SB; Radha V; Vimaleswaran KS; Mohan V
    Metab Syndr Relat Disord; 2010 Apr; 8(2):119-26. PubMed ID: 19900151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism.
    Ylönen SK; Salminen I; Lyssenko V; Virtanen SM; Groop L; Aro A; Saloranta C;
    Eur J Clin Nutr; 2008 Dec; 62(12):1432-9. PubMed ID: 17700648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor-gamma gene polymorphism and risk of cardiovascular disease in patients with diabetic nephropathy.
    Szeto CC; Chow KM; Poon PY; Kwan BC; Li PK
    Am J Nephrol; 2008; 28(5):715-22. PubMed ID: 18417957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.